Artelo Biosciences discloses potential Nasdaq $5M MVLS listing rule impact
Artelo Biosciences filed an 8-K under Item 8.01 disclosing that it was identified among approximately 180 Nasdaq-listed companies with a market value of listed securities below the new $5,000,000 MVLS threshold approved by the SEC on July 22, 2026. A temporary stay of the $5M MVLS Rule was announced on July 29, 2026, and on October 5, 2026 the SEC published for comment a Nasdaq proposal to modify the operative date to be upon termination of the temporary stay (comments due October 29, 2026). The Company stated i...
Key takeaways
Nasdaq $5M MVLS Rule: On July 22, 2026, the SEC approved Nasdaq's new rule requiring listed companies to maintain a market value of listed securities of at least $5,000,000, with non-compliant companies potentially subject to delisting proceedings.
Company identification: Artelo was among approximately 180 Nasdaq-listed companies initially identified as having an MVLS below the new $5,000,000 threshold.
Regulatory stay and proposal: A temporary stay of the $5M MVLS Rule was announced on July 29, 2026, and on October 5, 2026 the SEC published for comment a Nasdaq rule change to make the operative date effective upon termination of the stay (comments due October 29, 2026).
Uncertainty disclaimer: As of the filing date, the Company stated it has no information on the duration of the stay, whether the rule will be reinstated in current form, or whether modifications will be adopted.
Potential compliance steps: The Company listed possible actions to regain or maintain compliance, including raising capital through its existing at-the-market equity offering program or other equity/equity-linked financings, actions on warrants/other securities, advancing development programs, managing operating expenses, and other corporate actions.
No commitment to action: The Company has not committed to any particular course of action, is not soliciting proposals for any transaction, and does not intend to disclose further developments unless disclosure is appropriate or required.
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow ARTL in real time
Get material earnings, filing, IR, and earnings-call alerts by email.